Pioneer uses DNA profiling technology for microbiome strain classification
Perseus Biomics has been selected as a NutraIngredients Probiota Pioneer for its advanced optical mapping-based technology platform, DynaMAP.
Startups & innovation
“Small rituals can create meaningful change”: Vapsula’s bid to transform vitamin drinks
The French startup has introduced a novel way for wellness consumers to get their daily dose of vitamins and minerals.
Judges announce 2025 Probiota Pioneers
The editorial committee has selected three startups innovating in the field of microbiome science as the 2025 Probiota Pioneers.
Behind the bacterium innovation "for more sustainable sun protection"
Italian microbiome startup Bacfarm just won Shiseido’s annual startup competition with an innovation that can have uses in both topical and nutra sun care products. We spoke to the co-founder to learn more about how it could disrupt the category...
“Made for TikTok dreams”: behind new Gen Z beauty-from-within brand Glowery
French beauty and wellness brand Glowery is set to launch this week after five years in the making. We spoke to founder and CEO Alexandra Kolasinski to find out more...
Calling all innovators: Become a 2025 Probiota Pioneer
As global universities and major companies invest in probiotics, prebiotics and microbiome innovations, start-ups in these booming sectors face a surge of funding and opportunities. But with fierce competition, the challenge remains: How can emerging...
Tiny Health increases funding, broadens clinical outreach
Tiny Health, a start-up primarily focused on infant microbiome health during the first 1,000 days of life, is expanding its relationship with medical practitioners.
Probiota 2025: Early bird discount end this month!
With expert speakers confirmed from Ani Biome, the Lawson Health Research Institute, Örebro University, ETH Zurich, dsm-firmenich, Novonesis, IFF, Morinaga, Kerry, and more, the upcoming Probiota 2025 is not to be missed.
Green Bioactives collects grants to expand biomanufacturing platform
Plant cell culture manufacturer Green Bioactives (GBL) has secured over £300,000 to advance plant metabolite production in response to the climate crisis.